Natus Medical Inc (BABY) 40.64 $BABY The Cooper

New Post Public Reply Private Reply Replies (0) Message Board

Sep 4, 2016 at 7:23 AM

Natus Medical Inc (BABY) 40.64 $BABY

The Cooper Companies (COO) Beats Q3 Earnings, View Up
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 8:27AM CDT
The Cooper Companies Inc. (COO) reported adjusted earnings of $2.30 in the third quarter of 2016, beating the Zacks Consensus Estimate by 2 cents and improving 16.8% on a year-over-year basis.
BABY: 40.64 (+0.93), QDEL: 21.58 (-0.16), IDXX: 114.09 (+0.93), COO: 185.92 (+0.55)

FEI Shareholders Approve Thermo Fisher Deal (Revised)
Urmimala Biswas - Zacks Investment Research - Thu Sep 01, 4:44PM CDT
Shareholders of FEI recently approved mega $4.2 billion deal to be acquired by Thermo Fisher Scientific.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), TMO: 151.18 (+0.23), IDXX: 114.09 (+0.93)

Thermo Fisher Shareholders Approve FEI Deal, Grows in Electron Microscopy (Revised)
Urmimala Biswas - Zacks Investment Research - Thu Sep 01, 2:59PM CDT
Shareholders of Thermo Fisher recently approved its previously announced mega $4.2 billion acquisition of FEI Company.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), TMO: 151.18 (+0.23), IDXX: 114.09 (+0.93)

Becton, Dickinson Hits 52-Week High on Solid Q3, Outlook
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 10:13AM CDT
Shares of Becton, Dickinson and Company (BDX) scaled a new 52-week high of $178.79 on Jul 31, eventually closing nominally lower at $177.21.
BABY: 40.64 (+0.93), BDX: 177.32 (+0.30), MASI: 59.90 (+0.47), NUVA: 66.74 (+0.68)

Thermo Fisher Closes FEI Deal, Grows in Electron Microscopy
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 6:42AM CDT
Thermo Fisher Scientific, Inc. (TMO) recently completed its earlier announced mega $4.2 billion acquisition of FEI Company.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), TMO: 151.18 (+0.23), IDXX: 114.09 (+0.93)

Inogen Hits 52-Week High on Solid Q2 & Estimate Revision
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 8:01AM CDT
Share price of Inogen Inc (INGN) rallied to a new 52-week high of $59 on Aug 30, eventually closing a tad bit lower at $58.46.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), INGN: 58.11 (+0.16), NUVA: 66.74 (+0.68)

Veeva Systems (VEEV) Q2 Earnings, Revenues Top; View Up
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 7:57AM CDT
Veeva Systems (VEEV) reported adjusted earnings of 15 cents per share in the second-quarter fiscal 2017, a 20.9% increase on a year-over-year basis.
VEEV: 40.74 (+0.51), BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), NUVA: 66.74 (+0.68)

PetMed Remains Strong on New Order Sales; Reorder Dips
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 9:44AM CDT
On Aug 29, 2016, we issued an updated research report on PetMed Express (PETS). This nationwide pet pharmacy presently carries a Zacks Rank #2 (Buy).
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), PETS: 20.38 (+0.19), IDXX: 114.09 (+0.93)

Varian Medical Hits 52 week High, Oncology Prospects Bright
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:56AM CDT
Share price of Varian Medical rallied to a new 52-week high of $96.31 on Aug 29.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), VAR: 96.41 (+0.52), IDXX: 114.09 (+0.93)

INC Research Upgraded to Strong Buy on Estimate Revision
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 8:26AM CDT
On Aug 27, Zacks Investment Research raised INC Research Holdings Inc. (INCR) to a Zacks Rank #1 (Strong Buy).
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), ABCO: 42.22 (+0.04), INCR: 44.01 (+0.19)

Abaxis Hurt by Dismal Q1 Results & Fierce Competition
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 7:32AM CDT
Abaxis' (ABAX) first-quarter fiscal 2017 results disappointed us, with the company squarely missing the Zacks Consensus Estimate.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), ABAX: 49.50 (-0.90), IDXX: 114.09 (+0.93)

Cigna Okays 3D Mammogram: Is Hologic Poised to Gain?
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 6:55AM CDT
Hologic's (HOLX) Genius 3D mammogram is the only clinically proven test to detect cancer 15 months earlier than traditional 2D screenings.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), IDXX: 114.09 (+0.93), HOLX: 38.51 (+0.05)

5 Medical Device Stocks to Buy on Q2 Earnings
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 9:22AM CDT
We have picked five stocks on solid Zacks Rank.
ISRG: 688.37 (-1.32), BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), IDXX: 114.09 (+0.93), CRY: 16.23 (+0.39)

Edwards Lifesciences: Rallies on Strong THV Sales, View Up
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 5:05PM CDT
Geographically Edwards Lifesciences (EW) excelled in both the U.S. as well as overseas, particularly in its transcatheter heart valve (THV) product segment.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), EW: 115.85 (-0.02), IDXX: 114.09 (+0.93)

STERIS Hit by Currency Fluctuations, Customer Consolidation
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 10:27AM CDT
STERIS' (STE) first-quarter results exceeded the Zacks Consensus Estimate on bottom-line front, the top line failed to meet the same
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), STE: 71.00 (+0.89), IDXX: 114.09 (+0.93)

BioTelemetry (BEAT) Scales New 52-Week High on Solid Q2
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 8:14AM CDT
Share price of BioTelemetry rallied to a new 52-week high of $21.42 on Aug 18.
BABY: 40.64 (+0.93), BEAT: 18.82 (+0.12), CRY: 16.23 (+0.39), NUVA: 66.74 (+0.68)

Healthways: A Strong Buy on Solid Q2, Estimate Revision
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 7:54AM CDT
On Aug 16, Zacks Investment Research upgraded Healthways, Inc to a Zacks Rank #1 (Strong Buy).
BABY: 40.64 (+0.93), HWAY: 24.96 (+0.10), IDXX: 114.09 (+0.93), CRY: 16.23 (+0.39)

Masimo (MASI) Gets CE Mark for Respiration Sensor RAS-45
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 7:35AM CDT
Masimo recently announced the receipt of CE mark for RAS-45 respiration sensor for "rainbow acoustic monitoring" of respiration rate.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), CRY: 16.23 (+0.39), NUVA: 66.74 (+0.68)

Allscripts' (MDRX) Sunrise Platform Uptake on the Rise
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 8:47AM CDT
Allscripts Healthcare Solutions recently announced that its Sunrise platform has been selected by The Bahamian Ministry of Health and the Public Hospitals Authority.
BABY: 40.64 (+0.93), MDRX: 12.88 (-0.03), IDXX: 114.09 (+0.93), CRY: 16.23 (+0.39)

Teleflex Launches Advanced Percutaneous Surgical System
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 5:45AM CDT
Following the U.S. Food and Drug Administration's clearance, Teleflex Incorporated (TFX) announced the launch of its second generation Percuvance Percutaneous Surgical system.
BABY: 40.64 (+0.93), TFX: 185.59 (+1.49), IDXX: 114.09 (+0.93), CRY: 16.23 (+0.39)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

D-Wave Quantum Hit with Securities Fraud Lawsuit

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Championing Change: USTA Mid-Atlantic Gala's Impact

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

CVS Study: GLP-1 Drugs Effective But Costly

By Hannah Lewis Updated Nov 15, 2026 Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Investors Gear Up for Lennar Class Action Lawsuit

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Viking Ventures: Impacts of VK2735 on Obesity Examined

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Berry Street Integrates AI with What Matters: Human Touch

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...